C-RAD publishes its annual report for 2025
Idag, 15:00
Idag, 15:00
C-RAD's annual report for 2025 has today been published online in Swedish and English on the company's website, please visit https://c-rad.com/investors/financial-reports
The annual report describes significant events and financial information for 2025 and is available at www.c-rad.com. Printed annual report is available to shareholders and other interested parties at the company's head office.
The annual report is published in accordance with the reporting requirements in the European Single Electronic Format (ESEF). In accordance with the requirements in ESEF, the financial statements have been provided with XBRL tags. The ESEF files can be downloaded at www.c-rad.com.
For further information:
Tomas Blomquist, CEO, +46 (0)70 523 0163, investors@c-rad.com
Linda Frölén, CFO, +46 (0)70 303 3253, investors@c-rad.com
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com
This information is information that C-Rad is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-10 15:00 CEST.
Attachments
Idag, 15:00
C-RAD's annual report for 2025 has today been published online in Swedish and English on the company's website, please visit https://c-rad.com/investors/financial-reports
The annual report describes significant events and financial information for 2025 and is available at www.c-rad.com. Printed annual report is available to shareholders and other interested parties at the company's head office.
The annual report is published in accordance with the reporting requirements in the European Single Electronic Format (ESEF). In accordance with the requirements in ESEF, the financial statements have been provided with XBRL tags. The ESEF files can be downloaded at www.c-rad.com.
For further information:
Tomas Blomquist, CEO, +46 (0)70 523 0163, investors@c-rad.com
Linda Frölén, CFO, +46 (0)70 303 3253, investors@c-rad.com
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com
This information is information that C-Rad is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-10 15:00 CEST.
Attachments
Analys
Analys
1 DAG %
Senast



OMX Stockholm 30
1,00%
(vid stängning)
Boeing
Idag, 15:41
Bolagen bakom Artemis färd till månen
Plejd
Idag, 14:56
Plejd rusar efter rekordkvartal
OMX Stockholm 30
1 DAG %
Senast
3 110,16